Stevanato Group SpaSTVN
Price$19.98Intrinsic value$21.9610% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $21.96median of 6 methods · middle span $15-$28based on filings through 31 Dec 2025
Market Price $19.98Price as of 1 Oct 2026
Margin of Safety +9.9%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 30.6% (near-term consensus, capped) · years 2–5: 13.2%/yr (balance of the path).16.5% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 613.6%Yr 714.0%Yr 814.4%Yr 914.8%Yr 1015.2%
13.2% → 15.2%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1114.0%Yr 1212.8%Yr 1311.5%Yr 1410.3%Yr 159.1%Yr 167.9%Yr 176.7%Yr 185.4%Yr 194.2%Yr 203.0%
15.2% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 2 windows (5/6y) (limited history)15.2%
Discount rate (cost of equity) 8.6%
Volatility vs market (adjusted beta)0.82

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetStevanato Group SpaSTVNHealth Care
Valuation
P/E—
P/S5.2×
P/B4.2×
EV / Revenue5.5×
EV / EBITDA15.1×
Profitability
Gross margin29.0%
Operating margin16.8%
Net margin11.8%
FCF margin1.6%
Returns
ROE9.4%
ROA5.5%
ROIC7.9%
Growth
Revenue growth (YoY)21.8%
5-yr fwd EPS growth16.5%
Financial strength
Debt / Equity0.27×
Current ratio1.76×
Altman Z-Score—
Interest coverage—
Dividend yield0.3%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.